CommercialPrior AuthMedium impact
Pharmacy Medical Policy Updates
Blue Cross Blue Shield of Kansas·KS · Oncology, Neurology, Rheumatology +4 more·Pharmacy
Effective date
Mar 1, 2026
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Kansas is updating policies for multiple prescription drugs and medical pharmacy solutions, including specialty medications for multiple sclerosis, oncology, and rare diseases. These policy updates will be implemented on March 1, 2026, and may affect prior authorization requirements and coverage criteria for affected medications.
Action Required
By March 1, 2026: Billing and clinical teams must review updated prior authorization requirements for all listed medications including Brensocatib, Cibinqo, multiple sclerosis agents, oncology drugs like Blenrep and Opdivo, and other specialty medications. Access the Prior Authorization page on BCBSKS website to review specific formulary requirements and update internal protocols for obtaining prior authorizations. Contact BCBSKS provider relations representative for clarification on specific medication policies.